Liminal BioSciences Revenue and Competitors
Estimated Revenue & Valuation
- Liminal BioSciences's estimated annual revenue is currently $8.8M per year.
- Liminal BioSciences's estimated revenue per employee is $163,611
- Liminal BioSciences's total funding is $147.8M.
Employee Data
- Liminal BioSciences has 54 Employees.
- Liminal BioSciences grew their employee count by -10% last year.
Liminal BioSciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | General Counsel | Reveal Email/Phone |
3 | Director programme management | Reveal Email/Phone |
4 | Chief Talent Officer | Reveal Email/Phone |
5 | Associate Director, Biology | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | Associate Director, Human Resources | Reveal Email/Phone |
8 | Director, Regulatory CMC | Reveal Email/Phone |
9 | Senior Director Finance | Reveal Email/Phone |
10 | Director Quality | Reveal Email/Phone |
Liminal BioSciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is Liminal BioSciences?
Liminal BioSciences is a global biotechnology company that specialises in discovering, developing and commercializing novel small molecule compounds for respiratory, liver and renal diseases. We focus specifically on developing solutions for rare and orphan diseases.
keywords:N/A
$147.8M
Total Funding
54
Number of Employees
$8.8M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Liminal BioSciences News
Get Liminal BioSciences alerts: LMNL opened at $0.90 on Tuesday. The company has a market cap of $27.90 million, a PE ratio of...
Liminal BioSciences Inc, a clinical-stage biopharmaceutical company, focuses on discovery, development, and commercialization of novel small...
LAVAL, QC and CAMBRIDGE, England, March 14, 2022 /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the...
LAVAL, QC and CAMBRIDGE, England , Aug. 9, 2021 /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced today that, its subsidiary Prometic Biotherapeutics Inc. ("PBT") has entered into a definitive agreement to sell its Rare Pediatric Disease P ...
Other Companies in Laval
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $17.5M | 55 | 12% | N/A |
#2 | N/A | 56 | 115% | N/A |
#3 | $12.8M | 58 | 4% | N/A |
#4 | $7.6M | 58 | N/A | N/A |
#5 | $7.5M | 58 | -9% | N/A |